Stay updated on Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study page now presents an access-denied error (403), replacing the prior study content with a standard 403 page and site footer.
    Difference
    20%
    Check dated 2026-09-19T20:32:58.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page shows a new revision tag, updating the version from v3.6.5 to v3.6.6, which signals a minor update to the record. No study details or user-facing information appear to be affected.
    Difference
    0.1%
    Check dated 2026-08-29T19:03:01.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Results have been posted for the Ramucirumab + Pembrolizumab trial (Phase I/II), including RP2D details, endpoints, adverse events, and quality-of-life measures. The update also includes follow-up timelines and related documentation.
    Difference
    6%
    Check dated 2026-08-22T21:43:39.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous v3.6.4. This indicates a small update to the page's versioning without altering the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-08T18:02:33.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page revision stamp was updated from v3.6.3 to v3.6.4, signaling an update to the page. This reflects a version bump rather than a substantive content change.
    Difference
    0.1%
    Check dated 2026-07-25T10:24:53.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page revision is updated from v3.6.2 to v3.6.3, indicating a new revision of the study entry. This appears to be a metadata update rather than a change to study content or trial details.
    Difference
    0.1%
    Check dated 2026-07-03T22:53:33.000Z thumbnail image

Stay in the know with updates to Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page.